Webinar: Overcoming Biomarker Data Chaos with a Single Data Platform
Duration: 30 minutes
Register for the Webinar:
Translational and clinical research teams spend more than 70% of their time wrangling information from disconnected clinical trial data sets.
Data ends up in silos, making it hard to compile information and surface insights.
Watch this short webinar, where Adam Brown and Mike Waters will demonstrate how integrating exploratory biomarker, PK, and clinical data in a unified data platform enables teams to interrogate trends and identify insights as data is generated on-study.
May 23: Join QuartzBio at the Bioinformatics Strategy Meeting East Coast
Join QuartzBio at the 8th Annual Bioinformatics Strategy Meeting East Coast USA for the “Omics-Driven Approaches” track on 23 May 2022.
ROUNDTABLE DISCUSSION: "Turning Multi-omic Data Chaos into Translational Insights"
Mike Waters of QuartzBio will facilitate a discussion among 10-15 industry leaders around critical topics relevant to biomarker-rich clinical trials:
Read More →
From IHC to Immune Profiling: Managing Data Breadth and Depth to Inform Clinical Programs
January 10, 2022 — With immuno-oncology assets progressing in the clinic, a growing biotechnology company we work with faces an increasingly common challenge:
Their trials are generating large datasets across a wide range of assay modalities (Figure 1), but the data remains siloed.
In addition to clinical data coming from the clinical research organization (CRO), the velocity of data coming from an assay services laboratory continuously delivering biomarker data from flow cytometry, immunohistochemistry, and genomics platforms quickly becomes overwhelming. Still another, separate data stream comes from a specialty laboratory delivering T-cell receptor (TCR) profiling data.
Read More →
From Translational Teams to Biomarker Operations: The Cross-Functional Impact of a Fragmented Clinical Trial Data Ecosystem
August 31, 2021 — Clinical samples are moving across an increasing number of physical/virtual locations and data is delivered in an expanding array of file formats as clinical trials become increasingly more complex and data rich (report).
Biospecimens are analyzed using a variety of assay technologies, each generating its own set of reportables, quality control metrics and data/file formats. Data is delivered through multiple, disconnected pipelines (Figure 1).
This complexity creates obstacles for many functional groups within sponsor organizations:
Read More →
